# Phytochemical Profiling of the Halophyte Artemisia fukudo Makino and Its In Vitro Effects on Androgen‐Related Pathways Associated With Benign Prostatic Hyperplasia and Alopecia

**Authors:** Yun Na Kim, Jae Sun Lee, Min Gyu Park, Yu Jung Kim, Seon Min Lee, Kwang Hyun Hwang, Min Hye Yang, Bong‐Oh Kwon, Jung‐Rae Rho, Eun Ju Jeong

PMC · DOI: 10.1002/open.202500481 · ChemistryOpen · 2026-02-28

## TL;DR

This study explores the plant Artemisia fukudo and finds that its compounds may help treat prostate enlargement and hair loss.

## Contribution

The study identifies jaceidin and eupatilin as novel compounds with dual therapeutic potential for BPH and alopecia.

## Key findings

- Jaceidin inhibits 5α-reductase type 2 and downregulates BPH-related proteins in prostate cells.
- Eupatilin modulates Wnt/β-catenin signaling and upregulates VEGF and IGF-1, promoting hair growth.
- Artemisia fukudo contains bioactive compounds like scopoletin, jaceosidin, eupatilin, and jaceidin.

## Abstract

Artemisia fukudo Makino is a biennial halophyte from the Asteraceae family, known for its tolerance to high‐salinity soils. Based on the excellent activity of A. fukudo extract in regulating the 5α‐reductase type 2 (5αR2) enzyme, this study aimed to investigate the phytochemical properties and pharmaceutical potential of A. fukudo for treating benign prostatic hyperplasia (BPH) and alopecia. Eight compounds including sesquiterpenes (1
–4), coumarin (5), and flavonoids (6
–8) were isolated from 90% MeOH fraction of A. fukudo, and their structures were determined using NMR and MS experiments. Among the isolated compounds, compounds 5–7 were detected in HPLC‐DAD, and contents of compounds 5
–8 were successfully quantified using ESI‐MS. It was found that 90% MeOH fraction of A. fukudo contained scopoletin (5), jaceosidin (6), eupatilin (7), and jaceidin (8) at the concentration of 1.44, 35.71, 6.44, and 11.19 mg/g, respectively. Compound 8 effectively inhibited the expressions of BPH‐related proteins, AR, PCNA, PSA, and 5αR2 in LNCaP and RWPE‐1 cells. Meanwhile, compound 7 exhibited potent activity in regulating Wnt/β‐catenin signaling and induced the expression of VEGF and IGF‐1 in HaCaT and HUVECs. These findings suggest that A. fukudo and its bioactive constituents represent novel natural substances for treatment or improvement of BPH and alopecia.

This study investigated the phytochemical constituents of the halophyte Artemisia fukudo, leading to the isolation and identification of eight compounds characterized by HPLC–DAD and ESI–MS. Importantly, we demonstrate for the first time that jaceidin inhibits 5α‐reductase type 2 and downregulates BPH‐associated proteins (AR, PSA, and PCNA) in prostate cells, while eupatilin modulates Wnt/β‐catenin signaling and upregulates VEGF and IGF‐1, indicating hair growth–promoting activity. These findings reveal A. fukudo as a novel natural resource with dual therapeutic potential against benign prostatic hyperplasia and hair loss.© 2026 WILEY‐VCH GmbH

## Linked entities

- **Proteins:** AR (androgen receptor), PCNA (proliferating cell nuclear antigen), KLK3 (kallikrein related peptidase 3), VEGFA (vascular endothelial growth factor A), IGF1 (insulin like growth factor 1), ctnnb1.S (catenin beta 1 S homeolog)
- **Chemicals:** scopoletin (PubChem CID 5280460), jaceosidin (PubChem CID 5379096), eupatilin (PubChem CID 5273755), jaceidin (PubChem CID 5464461)
- **Diseases:** benign prostatic hyperplasia (MONDO:0010811), alopecia (MONDO:0004907)

## Full-text entities

- **Genes:** SRD5A2 (steroid 5 alpha-reductase 2) [NCBI Gene 6716], CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, TUBA1B (tubulin alpha 1b) [NCBI Gene 10376] {aka K-ALPHA-1}, FGF5 (fibroblast growth factor 5) [NCBI Gene 2250] {aka HBGF-5, Smag-82, TCMGLY}, ACHE (acetylcholinesterase (Yt blood group)) [NCBI Gene 43] {aka ACEE, ARACHE, N-ACHE, YT}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], KLK3 (kallikrein related peptidase 3) [NCBI Gene 354] {aka APS, KLK2A1, PSA, hK3}, AR (androgen receptor) [NCBI Gene 367] {aka AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, CYP4F3 (cytochrome P450 family 4 subfamily F member 3) [NCBI Gene 4051] {aka CPF3, CYP4F, CYPIVF3, LTB4H}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, FGF7 (fibroblast growth factor 7) [NCBI Gene 2252] {aka HBGF-7, KGF}
- **Diseases:** infections (MESH:D007239), LUTS (MESH:D059411), cholestasis (MESH:D002779), gastrointestinal diseases (MESH:D005767), cytotoxicity (MESH:D064420), BPH (MESH:D011470), AGA (MESH:D054880), urinary retention (MESH:D016055), malaria (MESH:D008288), gastritis (MESH:D005756), social phobia (MESH:D000072861), depression (MESH:D003866), psychiatric disorders (MESH:D001523), cancer (MESH:D009369), prostate adenocarcinoma (MESH:D000230), sexual dysfunction (MESH:D012735), anxiety (MESH:D001007), Chronic inflammation (MESH:D007249), gastric ulcers (MESH:D013276), prostate cancer (MESH:D011471), pain (MESH:D010146), fever (MESH:D005334), Alopecia (MESH:D000505), jaundice (MESH:D007565)
- **Chemicals:** capillarisin (MESH:C011185), chromone (MESH:D002867), polyacetylenes (MESH:D000078789), A. fukudo extract (-), silica (MESH:D012822), Finasteride (MESH:D018120), penicillin (MESH:D010406), coumarins (MESH:D003374), A. (MESH:D001151), DHT (MESH:D013196), PVDF (MESH:C024865), flavonoid (MESH:D005419), Eupatilin (MESH:C045325), scoparone (MESH:C018145), argon (MESH:D001128), ROS (MESH:D017382), glycosides (MESH:D006027), Scopoletin (MESH:D012603), CO2 (MESH:D002245), TP (MESH:D043343), MNX (MESH:D008914), sesquiterpenes (MESH:D012717), nitrogen (MESH:D009584), CH2Cl2 (MESH:D008752), jaceosidin (MESH:C477508), acetonitrile (MESH:C032159), streptomycin (MESH:D013307), carbon (MESH:D002244), silica gel (MESH:D058428), NaCl (MESH:D012965), Methanol (MESH:D000432), salt (MESH:D012492), PS (MESH:D010758), n-hexane (MESH:C026385), Formic acid (MESH:C030544), artemisinin (MESH:C031327), jaceidin (MESH:C548020), SDS (MESH:D012967), 13C (MESH:C000615229), Water (MESH:D014867), CCK-8 (MESH:D012844), testosterone (MESH:D013739), coumarin (MESH:C030123), terpenoids (MESH:D013729), essential oil (MESH:D009822)
- **Species:** Homo sapiens (human, species) [taxon 9606], Artemisia argyi (species) [taxon 259893], Mus musculus (house mouse, species) [taxon 10090], Artemisia capillaris (species) [taxon 265783], Artemisia fukudo (species) [taxon 637479], Artemisia annua (sweet Annie, species) [taxon 35608]
- **Mutations:** C0035C, X500R, 500 C
- **Cell lines:** HUVEC — Homo sapiens (Human), Finite cell line (CVCL_3722), KB — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0372), HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038), LNCaP — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0395), CVCL-0395 — Homo sapiens (Human), Fragile X syndrome, Transformed cell line (CVCL_8Z73), RWPE-1 — Homo sapiens (Human), Transformed cell line (CVCL_3791), 3T3-L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123), CRL-11609D — Homo sapiens (Human), Transformed cell line (CVCL_EX22), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), CRL-1740 — Homo sapiens (Human), Ataxia telangiectasia syndrome, Finite cell line (CVCL_JC92)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949454/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12949454/full.md

## References

86 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949454/full.md

---
Source: https://tomesphere.com/paper/PMC12949454